GNAQ promotes RHOA activation through ARHGEF25, which in turn regulates cellular functions by modulating cell proliferation and apoptosis, thereby influencing the progression of NKTCL (Figure 6). The gene discussed is RHOA; the disease is extranodal nasal NK/T cell lymphoma.